Carna Biosciences Inc
TSE:4572
Carna Biosciences Inc
TSE:4572
Price:
428 JPY
-2.28%
Market Closed
Updated:
Apr 27, 2024
Section:
Relative Value
The Relative Value of one
Carna Biosciences Inc
stock under the Base Case scenario is
490.44
JPY.
Compared to the current market price of 428 JPY,
Carna Biosciences Inc
is
Undervalued by 13%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
490.44
JPY
Undervaluation 13%
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Carna Biosciences Inc Competitors
Carna Biosciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Carna Biosciences Inc
TSE:4572
|
7.3B JPY | 4.5 | -6.4 | -4.2 | -4 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.8B USD | 5.2 | 37 | 22.8 | 33.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
182.6B USD | 4.2 | 22.6 | 16.5 | 20.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.6B USD | 2.8 | 31.4 | 17 | 26.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
38.1B CHF | 5.7 | 58.2 | 20 | 29.3 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.4B USD | 6 | 32.7 | 26.1 | 31.4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
54.8T KRW | 14.8 | 63.9 | 33.7 | 48.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 7 | 33.8 | 23.6 | 26.3 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.5B USD | 9 | 44.6 | 30.5 | 36.5 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.4B USD | 3.1 | 41.5 | 17.6 | 27.5 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.4 | 32.4 | 53.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
